SULT2B1 and neoplasm: Wang et al. have also reported that the SULT2B1-cholesterol sulfate-DOCK2 axis plays a vital role in inhibiting CD8+ T cell infiltration to the tumor microenvironment of hepatocellular carcinoma, which may affect immunotherapy efficacy (Wang et al., 2023).